| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,080 |
14,600 |
$906K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,573 |
8,370 |
$740K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,939 |
2,881 |
$217K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,500 |
2,465 |
$88K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,933 |
2,876 |
$68K |
| 99215 |
Prolong outpt/office vis |
428 |
421 |
$51K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
179 |
179 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
480 |
467 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
178 |
173 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
723 |
709 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
108 |
107 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
341 |
321 |
$7K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
42 |
42 |
$6K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
40 |
40 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
446 |
437 |
$3K |
| 80047 |
|
236 |
234 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
86 |
82 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
85 |
81 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
343 |
334 |
$3K |
| 81001 |
|
744 |
726 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
26 |
25 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
519 |
507 |
$2K |
| 87481 |
|
26 |
25 |
$892.40 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
26 |
25 |
$892.40 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
14 |
$771.41 |
| 81025 |
|
79 |
77 |
$664.80 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
53 |
49 |
$495.70 |
| 93000 |
|
24 |
24 |
$220.49 |
| 87210 |
|
32 |
31 |
$169.71 |
| 81003 |
|
60 |
59 |
$128.25 |
| 87186 |
|
15 |
12 |
$111.40 |
| 80076 |
|
12 |
12 |
$100.86 |